Indian benchmark equity indices reduced their initial gains and were in negative territory on Thursday, influenced by ...
STORY: Shares of Eli Lilly jumped Thursday morning after the company, known for its popular weight-loss drug Zepbound, forecast annual profit largely above Wall Street estimates.The outlook appeared ...
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...
Founded by a team of renowned physicians and researchers, QualityStar has become a global leader in advancing health and ...
The post contains 50 new customer stories, which appear at the beginning of each section of customer lists. The post will be ...
Why Elon Musk’s new government title is a big deal, Qualcomm rides strong chip demand to beat estimates, and more news to start your day.
Eli Lilly stock rose after the drugmaker posted quarterly earnings that beat Wall Street expectations, and issued upbeat 2025 guidance. Fourth-quarter adjusted earnings came in at $5.32 a share, above ...